I'm a neuroscience researcher completing my PhD in Behavioral Neuroscience at the University at Albany. My doctoral thesis uses meta-analytic methods to investigate whether standard laboratory housing systematically inflates preclinical cognitive effect sizes -- with direct implications for how we evaluate drug candidates in translational research.
Over 15 years I've worked at Cold Spring Harbor Laboratory, CUNY, and SUNY Albany. I've published in Cell (Impact Factor 64.5) and authored a first-author review in CNS Neuroscience & Therapeutics. I combine deep wet-lab expertise with strong quantitative skills in R, Python, meta-analysis, and Bayesian statistics. More about me
Recent writing
Insulin-like growth factor-2 is a promising candidate for the treatment and prevention of Alzheimer's disease
A comprehensive review of IGF-2 as a neurotrophic therapeutic agent for Alzheimer's disease, examining its neuroprotective mechanisms, effects on cognition and neuroplasticity, and potential as both a preventive and treatment intervention.